Special Report: Cancer screening feeds overdiagnosis debate | Reuters

The next frontier (or one of many?) on the cancer screening and over diagnosis debate, this time for esophageal cancer. The pattern is familiar, a new less expensive technology is developed, business practices and models provide incentives to create demand,  organizations note the lack of justification for expanded screening, and interest groups spring up advocating for increased screening. Quote:

“The unfortunate thing is … this is something that will be a money-maker for the people who offer it,” says Brawley of the American Cancer Society. In the absence of research showing that routine screening yields clear benefits, it’s premature to be doing it, “especially if they are charging for the procedure,” he says.

“This is marketing, that is all that is,” says Dr. H. Gilbert Welch, an internist at the Dartmouth Institute for Health Policy and Clinical Practice in Hanover, New Hampshire, and author of “Overdiagnosed: Making People Sick in the Pursuit of Health.”

Special Report: Cancer screening feeds overdiagnosis debate | Reuters.

About these ads

What do you think?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s